Houyanqing Oral Liquid

Developed for: mucositis
Investigated by: Affiliated Cancer Hospital & Institute of Guangzhou Medical University · Affiliated Cancer Hospital of Shantou University Medical College · Cancer Hospital Chinese Academy of Medical Science · Cancer Hospital of Guangxi Medical University · Eye & ENT Hospital of Fudan University · First Affiliated Hospital of Kunming Medical University
+11 more
· Fujian Cancer Hospital · Hunan Cancer Hospital · Sun Yat-sen University · Sun Yat-sen University Cancer Center · The Fifth Affiliated Hospital, Sun Yat-sen University · The First People's Hospital of Changzhou · West China Hospital · Wuzhou Red Cross Hospital · Xiangya Hospital of Central South University · Yunnan Cancer Hospital · Zhejiang Cancer Hospital

today NCT07311772 · Ph 3

20262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 3	NCT07311772	Dec 2025 → Mar 2027 expected	mucositis, nasopharyngeal carcinoma	Sun Yat-sen University	Recruiting	No outcome recorded

Every value below carries the sentence it was read from. 1 source stands behind the page.

Field	Value	Cited text
Known as	Houyanqing Oral Liquid	ClinicalTrials.gov intervention name — accepted as the source's own label NCT07311772 ↗
Modality	Traditional medicine (herbal / TCM)	“Houyanqing Oral Liquid is a Chinese herbal preparation” NCT07311772 ↗